Researchers have uncovered how mutations in the ATRX gene help aggressive gliomas grow by reshaping the way DNA is folded and organized inside cancer cells. This altered DNA structure switches on genes that promote tumor growth, spread, and survival. In laboratory and animal studies, blocking one of these pathways – particularly the HOXA gene family—slowed tumor growth, triggered cancer cell death, and improved survival. The findings suggest that targeting the downstream effects of ATRX mutations, rather than the mutation itself, could offer a more precise treatment strategy. Although further clinical studies are needed, this discovery opens new possibilities for personalized therapies against hard-to-treat brain cancers.
Read more at MedicalXpress